Antibiotic susceptibility profiles of neonatal invasive isolates of Escherichia coli from a 2-year nationwide surveillance study in Germany, 2009-2010

M Heideking; F Lander; M Hufnagel; Y Pfeifer; E Wicker; G Krause; R Berner

doi:10.1007/s10096-013-1871-3

Antibiotic susceptibility profiles of neonatal invasive isolates of Escherichia coli from a 2-year nationwide surveillance study in Germany, 2009-2010

Eur J Clin Microbiol Infect Dis. 2013 Sep;32(9):1221-3. doi: 10.1007/s10096-013-1871-3. Epub 2013 Apr 5.

Authors

M Heideking¹, F Lander, M Hufnagel, Y Pfeifer, E Wicker, G Krause, R Berner

Affiliation

¹ Center for Pediatrics and Adolescent Medicine, University Medical Center Freiburg, Freiburg, Germany.

PMID: 23558366
DOI: 10.1007/s10096-013-1871-3

Abstract

A nationwide 2-year surveillance study on invasive neonatal Escherichia coli infections in Germany was conducted. A total of 158 isolates were tested for antibiotic susceptibility. The empirical treatment regimen of ampicillin plus gentamicin for neonatal sepsis appears to remain effective, but emerging resistance needs to be closely monitored.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Anti-Bacterial Agents / therapeutic use*
Drug Resistance, Bacterial
Epidemiological Monitoring
Escherichia coli / drug effects*
Escherichia coli Infections / drug therapy*
Escherichia coli Infections / epidemiology*
Escherichia coli Infections / microbiology
Germany / epidemiology
Humans
Infant, Newborn
Microbial Sensitivity Tests

Substances

Anti-Bacterial Agents